Condition: Chronic Hep B · Chronic Hepatitis b · Chronic Hepatitis · Sponsor: Tune Therapeutics, Inc.
This study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Tune-401 in adult participants with Chronic Hepatitis B.
This description comes directly from the study's public registry record.
Tune Therapeutics, Inc. · 855 755 8863 · clinical.operations@tunetx.com
Always discuss trial participation with your own doctor first.
| Queen Mary Hospital, University of Hong Kong | Hong Kong, Hong Kong | Recruiting |
| PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit | Chisinau, Moldova | Recruiting |
| New Zealand Clinical Research | Auckland, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06671093